Clinical Trial

Comorbidities Resolution After MGB Surgery and Change in Body Composition

Study acronym: MOGAMBO
Recruiting
View on ClinicalTrials.gov →
Summary
This observational study aims to learn about the correlation between the improving comorbidities associated with obesity after MGB (Mini-Gastric Bypass) surgery and changes in body composition in morbidly obese patients. The main questions it aims to answer are: To study the correlation between the improving comorbidities associated with obesity after MGB(Mini-Gastric Bypass) surgery and changes in body composition. Other objectives are: * Changes in the parameters of the metabolic syndrome after surgery * Changes in the cardiovascular risk biomarkers after metabolic surgery * Emergence in complications arising out of surgery requiring any intervention or causing a prolonged hospital stay, or requiring additional outpatient visits. Type of Study: An observational study in which participants with morbid obesity will undergo mini-gastric bypass surgery as per routine protocol. No separate experimental interventions will be done in the study for the participants.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-08-23; most recent amendment 2026-02-16.
Status change: Not Yet Recruiting → Recruiting 2024-02-20
Trial Details
NCT Number NCT06015620
Lead Sponsor All India Institute of Medical Sciences, Bhubaneswar
Conditions Morbid Obesity, Type2diabetes, Sleep Apnea, Hypothyroidism, Hypertension, Lipid Disorder, Non-Alcoholic Fatty Liver Disease, Chronic Venous Hypertension With Ulcer
Enrollment 35 participants
Start Date 2023-09-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-18